
The current SOLV market cap is 12.97B. The company's latest EPS is USD 2.7689 and P/E is 27.08.
Year End December 30 2024 | 2023 | 2024 |
---|---|---|
USD ($) | USD ($) | |
Total Revenue | 8.24B | 8.25B |
Operating Income | 1.48B | 1.04B |
Net Income | 692M | 479M |
Year End December 30 2024 | 2023 | 2024 |
---|---|---|
USD ($) | USD ($) | |
Total Assets | 14.38B | 14.46B |
Total Liabilities | 10.97B | 11.5B |
Total Equity | 3.41B | 2.96B |
Market Cap | 12.97B |
Price to Earnings Ratio | 27.08 |
Price to Sales Ratio | 1.57 |
Price to Cash Ratio | 17.02 |
Price to Book Ratio | 4.38 |
Dividend Yield | - |
Shares Outstanding | 172.99M |
Average Volume (1 week) | 903.75k |
Average Volume (1 Month) | 1.26M |
52 Week Change | 8.45% |
52 Week High | 85.92 |
52 Week Low | 47.16 |
Spread (Intraday) | 10.71 (13.29%) |
Company Name | Solventum Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.solventum.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.